Literature DB >> 29566363

Cardiac-Specific Overexpression of Silent Information Regulator 1 Protects Against Heart and Kidney Deterioration in Cardiorenal Syndrome via Inhibition of Endoplasmic Reticulum Stress.

Dong Huang1, Mei-Ling Yan1, Kan-Kai Chen1, Rong Sun1, Zhi-Feng Dong1, Peng-Long Wu1, Shuai Li1, Guang-Shuo Zhu2, Shi-Xin Ma1, Ye-Sheng Pan1, Jing-Wei Pan1, Wei Zhu3, Jun Xu4, Meng Wei1, Jing-Bo Li1.   

Abstract

BACKGROUND/AIMS: Increased endoplasmic reticulum (ER) stress contributes to development of cardiorenal syndrome (CRS), and Silent Information Regulator 1 (SIRT1), a class III histone deacetylase, may have protective effects on heart and renal disease, by reducing ER stress. We aimed to determine if SIRT1 alleviates CRS through ER stress reduction.
METHODS: Wild type mice (n=37), mice with cardiac-specific SIRT1 knockout (n=29), or overexpression (n=29), and corresponding controls, were randomized into four groups: sham MI (myocardial infarction) +sham STNx (subtotal nephrectomy); MI+sham STNx; sham MI+STNx; and MI+STNx. To establish the CRS model, subtotal nephrectomy (5/6 nephrectomy, SNTx) and myocardial infarction (MI) (induced by ligation of the left anterior descending (LAD) coronary artery) were performed successively to establish CRS model. At week 8, the mice were sacrificed after sequential echocardiographic and hemodynamic studies, and then pathology and Western-blot analysis were performed.
RESULTS: Neither MI nor STNx alone significantly influenced the other healthy organ. However, in MI groups, STNx led to more severe cardiac structural and functional deterioration, with increased remodeling, increased BNP levels, and decreased EF, Max +dp/dt, and Max -dp/dt values than in sham MI +STNx groups. Conversely, in STNx groups, MI led to renal structural and functional deterioration, with more severe morphologic changes, augmented desmin and decreased nephrin expression, and increased BUN, SCr and UCAR levels. In MI+STNx groups, SIRT1 knockout led to more severe cardiac structural and functional deterioration, with higher Masson-staining score and BNP levels, and lower EF, FS, Max +dp/dt, and Max -dp/dt values; while SIRT1 overexpression had the opposite attenuating effects. In kidney, SIRT1 knockout resulted in greater structural and functional deterioration, as evidenced by more severe morphologic changes, higher levels of UACR, BUN and SCr, and increased desmin and TGF-β expression, while SIRT1 overexpression resulted in less severe morphologic changes and increased nephrin expression without significant influence on BUN or SCr levels. The SIRT1 knockout but not overexpression resulted in increased myocardial expression of CHOP and GRP78. Cardiac-specific SIRT1 knockout or overexpression resulted in increased or decreased renal expression of CHOP, Bax, and p53 respectively.
CONCLUSIONS: Myocardial SIRT1 activation appears protective to both heart and kidney in CRS models, probably through modulation of ER stress.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cardiorenal syndrome; Genetically Altered and Transgenic Models; Myocardial Infarction; Nephrology and Kidney; Remodeling

Mesh:

Substances:

Year:  2018        PMID: 29566363     DOI: 10.1159/000488404

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  2 in total

1.  Panax Notoginseng Saponins Protect Cardiac Myocytes Against Endoplasmic Reticulum Stress and Associated Apoptosis Through Mediation of Intracellular Calcium Homeostasis.

Authors:  Jun Chen; Rui Xue; Li Li; Li Li Xiao; Jiahong Shangguan; Wenjing Zhang; Xueyang Bai; Gangqiong Liu; Ling Li
Journal:  Front Pharmacol       Date:  2019-09-20       Impact factor: 5.810

2.  Melatonin promotes sirtuin 1 expression and inhibits IRE1α-XBP1S-CHOP to reduce endoplasmic reticulum stress-mediated apoptosis in chondrocytes.

Authors:  Kunpeng Qin; Hao Tang; Yi Ren; Di Yang; Yetian Li; Wei Huang; Yunfeng Wu; Zongsheng Yin
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.